KOJIN THERAPEUTICS
Founded by Stuart Schreiber, Benjamin Cravatt, Stephanie Dougan, and Vasanthi Viswanathan, Kojin is accelerating a drug discovery platform that connects complex cell states to known biochemical processes such as ferroptosis, or iron-dependent cell death, and enables the development of selective therapies for a broad range of hard-to-treat diseases. The company’s investors include Polaris Partners, Newpath Partners, Cathay Health, Leaps by Bayer, AbbVie Inc., Eventide Asset Management, Alexandria, and the Dana-Farber Cancer Institute venture firm, Binney Street Capital.
KOJIN THERAPEUTICS
Industry:
Biopharma Biotechnology Health Care Life Science Medical
Founded:
2020-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.kojintx.com
Total Employee:
11+
Status:
Active
Total Funding:
60 M USD
Technology used in webpage:
Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS
Similar Organizations
Arcellx
Arcellx is a clinical-stage biotechnology company that provides patients with immune cell therapies.
Eikon Therapeutics
Eikon Therapeutics is a biopharmaceutical company that develops live-cell resolution microscopy and engineering for drug discovery.
Emmaus Medical
Emmaus Medical is a pharmaceutical company developing new treatments for rare diseases and conditions.
Gennao Bio
Gennao Bio is a genetic medicines company that develops targeted nucleic acid therapeutics to cure muscle diseases.
Harmony Biosciences
Harmony Biosciences is a pharmaceutical company that develops and commercializes novel therapies for rare neurological disorders.
Novellus
Novellus is a biotechnology company working to develop engineered cellular medicines.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Zosano Pharma
Zosano Pharma is a biopharmaceutical company, develops products based on the transdermal delivery technology.
Current Advisors List
Board_member
Board_member
Board_member
2019-03-05
Board_member
Board_member
Board_member
Current Employees Featured
Luba Greenwood Director Board Of Directors @ Kojin Therapeutics
Director Board Of Directors
2021-06-01
Luba Greenwood CEO @ Kojin Therapeutics
CEO
2021-09-01
Founder
Investors List
Leaps by Bayer
Leaps by Bayer investment in Series A - Kojin Therapeutics
AbbVie
AbbVie investment in Series A - Kojin Therapeutics
Polaris Partners
Polaris Partners investment in Series A - Kojin Therapeutics
Alexandria Venture
Alexandria Venture investment in Series A - Kojin Therapeutics
Eventide
Eventide investment in Series A - Kojin Therapeutics
Cathay Capital
Cathay Capital investment in Series A - Kojin Therapeutics
Binney Street Capital
Binney Street Capital investment in Series A - Kojin Therapeutics
Newpath Management
Newpath Management investment in Series A - Kojin Therapeutics
Key Employee Changes
| Date | New article |
|---|---|
| 2021-10-14 | Kojin Therapeutics Announces Luba Greenwood as Chief Executive Officer |
Official Site Inspections
http://www.kojintx.com Semrush global rank: 5.69 M Semrush visits lastest month: 1.48 K
- Host name: 151.101.2.159
- IP address: 151.101.2.159
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Kojin Therapeutics"
Home • Kojin Therapeutics
He joined the company in 1986 as a research scientist and has held various positions of increasing responsibility in the Discovery organization. Dr. Davidsen has been a critical leader in building AbbVie’s Oncology pipeline, directing …See details»
Kojin Therapeutics - Crunchbase Company Profile
Founded by Stuart Schreiber, Benjamin Cravatt, Stephanie Dougan, and Vasanthi Viswanathan, Kojin is accelerating a drug discovery platform that connects complex cell states to known biochemical processes such as ferroptosis, or …See details»
Kojin TX Company Profile 2025: Valuation, Funding
Publication ID Patent Title Status First Filing Date Technology (CPC) Citations; AU-2023284453-A1: Methods and compositions for initiating, regulating, and modulating weight loss and therapeutic applications thereofSee details»
Kojin Therapeutics - LinkedIn
Kojin Therapeutics | 6,079 followers on LinkedIn. Developing transformative medicines based on a groundbreaking approach to ferroptosis and cell state biology | Based in Boston, …See details»
Leaps by Bayer
Approach. Kojin Therapeutics is the first biopharmaceutical company using a proprietary approach to cell state and ferroptosis biology to develop novel therapeutics for diseases of high unmet need.See details»
Kojin Therapeutics Information - RocketReach
Kojintx.com; 1 212573XXXX; View Similar People. Related Companies Sigilon Therapeutics, Inc. 57 $11.4m Reviewed, part of the USA TODAY Network. 83 $52m FogPharma. 160 $5.5m …See details»
Kojin Therapeutics - Overview, News & Similar companies
Oct 14, 2021 Kojin Therapeutics contact info: Phone number: (781) 299-7800 Website: www.kojintx.com What does Kojin Therapeutics do? Kojin Therapeutics is the first …See details»
Kojin Therapeutics Company Profile | Management and ... - Datanyze
Www.kojintx.com Kojin Therapeutics Profile and History Kojin Therapeutics is the first biopharmaceutical company using a proprietary approach to cell state and ferroptosis biology …See details»
Harvey J . Berger, M.D. Joins Kojin Therapeutics as Chairman, …
Harvey J . Berger, M.D. Joins Kojin Therapeutics as Chairman, President, and Chief Executive Officer Read MoreSee details»
About KOJIN THERAPEUTICS | DxMultiomics
Kojintx.com Mark Based in Boston, Massachusetts and named after the Japanese deity that tamed fire for the good of humanity, Kojin is harnessing groundbreaking discoveries in cell …See details»
Board of Directors Archives • Kojin Therapeutics
Pioneering cell-state and ferroptosis biology and cutting-edge drug discoverySee details»
Kojin Therapeutics - MassBio
Kojin is harnessing groundbreaking discoveries in cell-state and ferroptosis biology to develop first-in-class treatments for use in patients with various forms of cancer, as well as …See details»
Kojin Therapeutics - VentureRadar
"Kojin is harnessing groundbreaking discoveries in cell state and ferroptosis biology to create novel therapies and cures for diseases traditionally considered intractable.See details»
Kojin Therapeutics - Company Profile & Staff Directory - ContactOut
Https://kojintx.com. Employees: 11-50 employees View all Kojin Therapeutics employees. Industry: Biotechnology Location: 1 Kendall Sq, Building 200, Suite 001, Cambridge, …See details»
Microsoft Word - Press Release_KojinTx_Final …
2 Dr. Berger added, "I am grateful for the opportunity to take on the leadership of Kojin at this critical time and to collaborate closely again with Stuart Schreiber, our other scientific advisors, …See details»
Kojin Therapeutics Launches with $60 Million Series A to
Jun 9, 2021 Kojin Therapeutics Inc., the leading company developing new targeted therapeutics based on cell state and ferroptosis biology, launched with a $60 million Series A led by Polaris …See details»
Kojin Therapeutics Raises $60 Million in Series A Funding to …
Jun 9, 2021 Founded by leading scientists, including Stuart Schreiber and Benjamin Cravatt Series A led by Polaris Partners, Newpath Partners and Cathay Health, the global cross …See details»
Kojin Therapeutics Email Formats & Email Address Examples | LeadIQ
Frequently Asked Questions What does Kojin Therapeutics do? Kojin Therapeutics was founded in 2020. The company's main headquarters is located in 451 D St Suite 502 Boston, …See details»
Join Us • Kojin Therapeutics
We are a team of passionate scientists developing breakthrough medicines to modulate ferroptosis. We pioneer cell-state and ferroptosis biology to create cutting-edge drug discovery …See details»
Kojin Therapeutics | CipherBio
Explore Kojin Therapeutics's investment information, scientific platforms, therapeutic approaches, indications and more here!See details»